tiprankstipranks
Trending News
More News >

Mark Hopman Insider Profile

4 Followers
Mark Hopman, CCO at Beta Bionics, Inc., holds 34.13K shares in Beta Bionics, Inc. (Ticker: BBNX). Most recently, Mark Hopman Sold $868 shares of Beta Bionics, Inc. on Jun 04, 2025 for an estimated value of 15.52K.
tipranks
Mark Hopman

Mark Hopman
Beta Bionics, Inc. (BBNX)
CCO

Not Ranked
Mark Hopman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$515K
100.00%
A breakdown of Mark Hopman's holdings

Insider Roles

Beta Bionics, Inc.
(BBNX)
CCO
Roles that Mark Hopman holds in companies

Most Profitable Insider Trade

Stock:
Beta Bionics, Inc.
(BBNX)
Rating:Informative Sell
Date:Jun 04, 2025 - Today
Return:+15.60%
The most profitable trade made by Mark Hopman

Mark Hopman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Beta Bionics, Inc.
Jun 04, 2025
CCO
Informative Sell
15.52K
$515.05K
Success Rate for
BBNX
1 out of 1 profitable transactions on
BBNX
100%
Average Return for
BBNX
Average return per transaction on
BBNX
+15.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 03, 2025
Uninformative Buy
$0.00
-
$0.00
Jun 04, 2025
Informative Sell
$15.52K
-
$17.88
+15.60%
List of latest transactions for each holding click on a transaction to see Mark Hopman's performance on stock

Mark Hopman insider profile FAQ

What is the percentage of profitable transactions made by Mark Hopman?
The percentage of profitable transactions made by Mark Hopman is ―.
    What is the average return per transaction made by Mark Hopman?
    The average return per transaction made by Mark Hopman is ―.
      What stocks does Mark Hopman hold?
      Mark Hopman holds: BBNX stocks.
        What was Mark Hopman’s latest transaction?
        Mark Hopman latest transaction was an Informative Sell of $15.52K.
          What was Mark Hopman's most profitable transaction?
          Mark Hopman’s most profitable transaction was an Informative Sell of BBNX stock on June 4, 2025. The return on the trade was 15.60%.
            What is Mark Hopman's role in Beta Bionics, Inc.?
            Mark Hopman's role in Beta Bionics, Inc. is CCO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.